CLC Number:
- R473.73
| [1] Zhang RX, Wu XJ, Wan DS,et al.Celecoxib can preventcapecitabine-related handfoot syndrome in stage Il and IIlcolorectal cancer patients: result of a single-center, prospective randomized phase III trial[J]. Ann Oncol, 2012, 23(5):1348-1353.DOI: 10.1093/annonc/mdr400. [2] Heo YS,Chang HM, Kim TW,et al.Hand-foot syndrome inpatients treated with capecitabine-containingcombination-chemotherapy[J]. J Clin Pharmacol, 2004, 44(10):1166-1172.DOI: 10.1177/0091270004268321. [3] Benson AB, Venook AP, Al-Hawary MM, et a1. Colon cancer, version 2.2021,NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2021,19(3):329-359. DOI:10.6004/jnccn.2021.0012. [4] 董元鸽,陆箴琦,杨瑒.卡培他滨致手足综合征的护理研究进展[J].护理研究(下旬版),2016(1):275-278. [5] 黄玉,王绍霞.恶性肿瘤化疗所致手足综合征国内外研究进展[J].中医临床研究,2018,10(3):86-89. [6] Sail MW.Capecitabine and hand—foot syndrome[J].J Expert Opin Drug Saf,2011, 10(2):159-169.DOI:10.1517/14740338.2011.546342. [7] Hofheinz RD, Cencer D,Schulz H,et al.Mapisal versus urea cream as prophylaxis for capecitabine-associated hand-foot syndrome: a randomized phase Ⅲ trial of the AIO quality of life working group[J]. J Clin Oncol,2015,33(22):2444-2449.DOI: 10.1200/JCO.2014.60.4587. [8] 梁琳春,褚斌斌.尿素乳膏联合VitB6防治手足综合征的临床观察[J].现代实用医学,2015,27(3):397-416. [9] Jacobi U,Waibler E,Schulze P,et a1.Release of doxorubicin in sweat:first step to induce the Palmar-plantar erythrodysesthesia syndrome?[J].Ann Oncol, 2005, 16(7):1210-1211.DOI: 10.1093/annonc/mdi204. [10] Yoshifuku A, Higashi Y, Matsushita S, et al.Transdermal nicotine patches for eosinophilic pustular folliculitis[J]. J Dermatol, 2013, 40(9):711-714.DOI:10.1111/1346-8138.12211. [11] 周胜涟,陈州华,徐婪,等. 芪归通络汤防治化疗后手足综合征的临床研究[J].湖南中医杂志,2016,32(9):11-14.DOI:10.16808/j.cnki.issn1003-7705.2016.09.004. [12] 陈红英,沙建飞,顾永伟.参地二仙汤治疗卡培他滨所致的手足综合征37例[J].陕西中医,2015(6):714-715. [13] 黄映飞,郭智涛.黄芪桂枝五物合补阳还五汤外用熏洗防治乳腺癌希罗达手足综合征52例临床观察[J].中外医学研究,2014,12(34):43-44.DOI:10.14033/j.cnki.cfmr.2014.34.024. [14] 李小军,冯春兰,罗海亮,等.八珍汤辅助化疗治疗中晚期食管癌45例临床观察[J].中医杂志,2016,57(5):416-419.DOI:10.13288/j.11-2166/r.2016.05.014. [15] 袁春樱,黄琼,韩伍龙.黄芪桂枝五物汤合当归四逆汤外洗防治卡培他滨所致手足综合征的临床观察[J].黑龙江中医药,2014(5):31-32. [16] 程小伟,吴锐荣,张振勇,等.中药熏洗治疗结直肠癌患者化疗后手足综合征的疗效观察[J].实用临床医药杂志,2020,24(21):32-35. [17] 张方圆,吕苏梅,杨玄,等.中国癌症症状管理实践指南——皮肤反应[J].护士进修杂志,2019,34(22):2017-2024.DOI:10.16821/j.cnki.hsjx.2019.22.001. [18] 崔秀秀,黄敬文,安丽凤,等.中药三七及其活性成分促进皮肤创面愈合的研究进展[J].现代中西医结合杂志,2023,32(21):3038-3043. [19] 廖佳伟,金晨,陈志,等.鸡血藤化学成分、药理作用研究进展及其质量标志物(Q-Marker)预测[J].中草药,2023,54(20):6866-6877. [20] 王彤,王崇静,王珩,等.龙血竭的临床应用研究概况[J].中国医药创新,2015,12(16):154-156. [21] National Cancer Institute. Common Terminology Criteria for Adverse Events(CTCAE)[EB/OL].(2018-03-11)[2019-09-04].https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. [22] Abushullaih S, Saad ED, Munsell M, et al.Incidence and severity of hand-foot syndrome in eolorectal cancer patients treated with cape cita bine: a single-institution experience[J]. Cancer Invest, 2002, 20(1):3-10.DOI: 10.1081/cnv-120000360. [23] 王君,徐力.社区管理模式对中晚期肺癌癌痛患者生活质量的研究[J]. 中医临床研究,2018,10(5):24-26. [24] 马国华. 三七散、三七粉联合用药预防人工膝关节置换术后DVT的临床观察[J].中国现代药物应用,2017,11(17):139-140.DOI:10.14164/j.cnki.cn11-5581/r.2017.17.078. [25] 康梦娇,张伟,林潼,等.重构本草——鸡血藤[J].吉林中医药,2023,43(1):95-98.DOI:10.13463/j.cnki.jlzyy.2023.01.023. [26] 盖龙娴,武霞.湿润烧伤膏联合龙血竭防治乳腺癌改良根治术后放射性皮肤损伤疗效观察[J]. 中国烧伤创疡杂志,2020,32(3):202-206. [27] 赵德华,王继生,楚明明,等.抗肿瘤药物引起手足综合征的机制及防治措施[J]. 中国现代应用药学,2019(11):1437-1442.DOI:10.13748/j.cnki.issn1007-7693.2019.11.026. |
| [1] | CAO Min, ZHANG Pei-li, HOU Xiao-ya, GAO Chao-yue, GUO Lin-fang, LI Ying. Nutritional care experience of caregivers of colorectal cancer patients undergoing chemotherapy based on ABC-X model: a qualitative study [J]. Journal of Nursing, 2025, 32(2): 13-18. |
| [2] | LIU Qi, LIU Jia-li, LIU Yu, YANG Li-min, FAN Yu-ying, LV Xing, JIN Hui-ying. Physical-psychological symptom burden trajectories and influencing factors in nasopharyngeal carcinoma patients during induction chemotherapy plus concurrent chemoradiotherapy [J]. Journal of Nursing, 2025, 32(1): 1-6. |
| [3] | . [J]. Journal of Nursing, 2025, 32(1): 39-43. |
| [4] | YAO Wan-qing, YANG Li-zhuang, CHEN Dan-dan, ZHANG Wan-qiu, LU Wei, GUAN Cui-hong, LI Hai. Efficacy of different non-drug interventions on cancer-related fatigue in breast cancer patients: a network Meta-analysis [J]. Journal of Nursing, 2024, 31(24): 37-43. |
| [5] | DAI Qian, LIU Xiang-yu, ZHU Xiao-mei, WANG Jia-li, HUANG Yuan-si. Status quo of self-compassion in patients with colorectal cancer stoma and its influencing factors [J]. Journal of Nursing, 2024, 31(23): 13-17. |
| [6] | . [J]. Journal of Nursing, 2024, 31(22): 73-78. |
| [7] | LI Yue-ge, KONG Han, CAO Ding, LI Jia-xin, SHANG Ya-meng, CHANG Shu-ying. Current status of fear of cancer recurrence in young and middle-aged patients with cervical cancer after surgery and its influencing factors: a 228-case study [J]. Journal of Nursing, 2024, 31(20): 8-12. |
| [8] | . [J]. Journal of Nursing, 2024, 31(20): 19-23. |
| [9] | . [J]. Journal of Nursing, 2024, 31(20): 29-32. |
| [10] | . [J]. Journal of Nursing, 2024, 31(18): 30-34. |
| [11] | GENG Yu-fang, QIN Ru-meng, WANG Hui, ZHANG Shan-shan, ZHOU Li-hua. Construction of post-traumatic growth model of ovarian cancer patients based on interpretative phenomenological analysis [J]. Journal of Nursing, 2024, 31(18): 73-78. |
| [12] | . [J]. Journal of Nursing, 2024, 31(17): 51-56. |
| [13] | YU Feng, SUN Li, HU De-ying, HU Jie, WANG Jia-qing, LV Chu-feng. Competency model of suicide gatekeeper for oncology nurses based on behavioral event interview and expert consultation [J]. Journal of Nursing, 2024, 31(17): 73-78. |
| [14] | . [J]. Journal of Nursing, 2024, 31(16): 56-61. |
| [15] | ZHANG Shu-zhen, YU Wen-ru, ZHANG Jun-feng, JIANG Jia-yao, LUO Mei, LIN Bi-yu, MAI Min-wen, YANG Meng-ting. Evidence-based nursing practice in prevention and management of radiation dermatitis in cancer patients undergoing radiotherapy [J]. Journal of Nursing, 2024, 31(16): 62-66. |
|
||